Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    8857018 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection
Intervention: Drug: IL-2 plus Anti-TNF or Thalidomide
2 Completed Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
Condition: HIV Infections
Intervention: Drug: Aldesleukin

Indicates status has not been verified in more than two years